CECC announces recommendations on further vaccination for people taking part in clinical trials of COVID-19 vaccines not approved by Taiwan's FDA

On December 23, the Central Epidemic Command Center (CECC) reported that considering that some individuals have volunteered to participate in clinical trial programs of COVID-19 vaccine candidates, the Advisory Committee on Immunization Practices (ACIP) at the Ministry of Health and Welfare recommended that such individuals can receive another COVID-19 vaccine approved in Taiwan 28 days after their last dose of the COVID-19 vaccine candidate, if they wish to receive further vaccination, after discussing it with the research team of the clinical trial and a physician's assessment. The ACIP made the recommendations after evaluating vaccination policies in other countries.

發佈日期 2021/12/23